Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

2.
4.

The role of vascular endothelial cells in the regulation of fibrinolysis.

Grulich-Henn J, Müller-Berghaus G.

Z Kardiol. 1989;78 Suppl 6:25-9. Review.

PMID:
2694664
5.

Habutobin releases plasminogen activator (U-PA) from bovine pulmonary artery endothelial cells.

Sunagawa M, Hanashiro K, Nakamura M, Kosugi T.

Toxicon. 1996 Jun;34(6):691-9.

PMID:
8817813
6.

Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.

Sprengers ED, Verheijen JH, Van Hinsbergh VW, Emeis JJ.

Biochim Biophys Acta. 1984 Sep 28;801(2):163-70.

PMID:
6541058
7.
8.

Comparison of fibrinolytic activities of human and bovine endothelial cells.

Bartha K, Wojta J, Wagner OF, Binder BR.

Am J Physiol. 1988 Jun;254(6 Pt 2):R885-90.

PMID:
3132861
9.
10.

Fibrinolytic system of cultured rabbit aortic endothelial cells.

al-Azhary DB, Wojta J, Binder BR.

Thromb Res. 1994 Sep 1;75(5):559-68.

PMID:
7992256
11.
12.

Factors contributing to increased vascular fibrinolytic activity in mongrel dogs.

Lang IM, Marsh JJ, Konopka RG, Olman MA, Binder BR, Moser KM, Schleef RR.

Circulation. 1993 Jun;87(6):1990-2000.

PMID:
8504514
13.

Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.

Sakata Y, Loskutoff DJ, Gladson CL, Hekman CM, Griffin JH.

Blood. 1986 Dec;68(6):1218-23.

14.
15.

Glucocorticoids stimulate plasminogen activator production by rat granulosa cells.

Wang C, Leung A.

Endocrinology. 1989 Apr;124(4):1595-601.

PMID:
2784380
16.

Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells.

van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J, van Muijen GN.

Blood. 1990 Apr 1;75(7):1490-7.

18.

Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.

Schultze AE, Roth RA.

Toxicol Appl Pharmacol. 1993 Sep;122(1):7-15.

PMID:
8378934
19.

Type 1 plasminogen activator inhibitor and its potential influence on thrombolytic therapy.

Loskutoff DJ.

Semin Thromb Hemost. 1988 Jan;14(1):100-9. Review. No abstract available.

PMID:
3127883
20.

Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.

Colucci M, Altomare DF, Chetta G, Triggiani R, Cavallo LG, Semeraro N.

Thromb Haemost. 1988 Aug 30;60(1):25-9.

PMID:
3142090

Supplemental Content

Support Center